ICER produced a comprehensive white paper on diagnostic testing for Alzheimer’s disease that was presented to the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC).
Date of review: January 2013
For questions, contact info@icer.org.
Intervention of interest: Diagnostics for Alzheimer’s disease
Final Documents
Below you will find the final documents from the policy paper review process:
Public Comments
Closed